New releases for the Biomedical & Life Sciences collection

Submitted by Alonzo LaMont on Wed, 01/20/2016 - 12:15pm

We're happy to report that medical updates have arrived:

“This month's releases to The Biomedical & Life Sciences Collection include a new mini-series on Future Directions in Therapeutic Intervention, Diagnostics and Prophylactics. As the development of new treatments and diagnostic tools requires a lot of effort and a lot of money, it is important to consider numerous factors before choosing to pursue a specific research path. This new series, containing five lectures delivered by experts from the pharmaceutical industry, presents a range of future directions for the prevention, diagnosis and treatment of diseases, their promises and pitfalls. This will be of great interest to researchers and practitioners in many fields as it provides a glimpse into cutting-edge therapeutic approaches.

Furthermore, five existing series were supplemented with new talks, among them is the Obesity: science, medicine and society series launched last month, which was augmented by two lectures discussing the genetics of monogenic obesity and obesity management. Our Cancer Genetics series was added with a talk on glioblastoma and the Vaccines series now includes a lecture on relevant preclinical studies. Another talk, which is series-independent, deals with immunotherapy for head and neck cancer. A full list of the newly released talks is provided below.”

(All Johns Hopkins University faculty and students have unlimited access to all the lectures through www.hstalks.com/access/)

New series: Future Directions in Therapeutic Intervention, Diagnostics and Prophylactics

Therapeutic targeting of the intestinal barrier in inflammatory bowel disease and graft-versus-host disease
Dr. Sam Nalle – Genentech, USA

Epigenetics as a paradigm for cancer treatment: chemically targeting the histone lysine methyltransferase EZH2
Dr. Sharad K. Verma – GlaxoSmithKline, USA

Targeting microRNAs in cancer
Dr. Molly Taylor – AstraZeneca, UK

Quantitative analysis of receptor allosterism and its implication for drug discovery
Dr. Rumin Zhang – Merck, USA

Antisense oligonucleotides: the promise and the problems
Dr. Kendall S. Frazier – GlaxoSmithKline, USA

New talks in Obesity: science, medicine and society:

Genetics of monogenic obesity: part 1 of 2Genetics of monogenic obesity: part 2 of 2
Prof. Dr. Johannes Hebebrand – University Hospital Essen, Germany
Prof. Dr. Anke Hinney – University Hospital Essen, Germany

Obesity management: lifestyle and bariatric surgery - part 2 of 2Obesity management: lifestyle and bariatric surgery - part 1 of 2
Prof. John Wilding – University of Liverpool, UK

New talk in Cancer Genetics:

The genetics of glioblastoma
Dr. Hai Yan – Duke University School of Medicine, USA

New talk in Vaccines:

Vaccine preclinical studies - part 1 of 2Vaccine preclinical studies - part 2 of 2
Dr. Rebecca Sheets – Grimalkin Partners

New talk in Back Pain Management:

Back pain: are we measuring the right things?
Prof. Rob Froud – Warwick Medical School, UK

New talk in Animal Models in Biomedical Research:

Legal and ethical aspects of using animals in research in the EU
Dr. Judy A. MacArthur Clark – Animals in Science Regulation Unit (ASRU), Home Office, UK

A new independent talk:

Immune checkpoint blockade and head and neck cancer
Dr. Jonathan Schoenfeld – Harvard University